
PDRN, exosomes, and NMN.
In the worlds of beauty and wellness, these three terms have become far more common to encounter.
“Nurturing the skin.”
“Restoring balance from the cellular level.”
“Supporting regenerative power.”
They are often introduced with phrases like these, and each carries an image of “next-generation beauty.”
In reality, however, these three are not the same thing.
✔︎ PDRN approaches things from the environment in which skin and tissue repair themselves.
✔︎ Exosomes focus on communication between cells.
✔︎ NMN approaches things through NAD+, from the standpoint of energy metabolism and the condition of the whole body.
In 2026, research on each of them has gradually advanced. At the same time, precisely because we now know more, it has become necessary to separate “what we can reasonably expect” from “what is still unknown.”
In this article, including the latest research trends as of September 2026, we’ll sort out the differences between PDRN, exosomes, and NMN, and how far “regenerative beauty” has come today.
There is no single, medically unified definition of the term “regenerative beauty.”
In the beauty world, it generally refers to approaches that:
— such approaches are sometimes referred to, in a broad sense, as regenerative beauty.
Whereas aesthetic medicine until now has centered on treating the “concerns you can see right now,”
such as
“removing spots,”
“filling wrinkles,”
and “lifting sagging skin,”
In regenerative beauty, the perspective has broadened toward “how to support the skin’s and body’s own ability to return to a healthy state.”
However, “regeneration” does not equal “rejuvenation.”
There is no completed treatment that fully returns cells to a youthful state or turns back time; most of these approaches are still in the midst of research and development.
What has changed most over the past few years is not simply that there are more new ingredients.
It’s that discussion has grown beyond “how does it work” to “how much evidence is there?” and “how should we view the differences between products?”
In 2026 in particular, this trend is unmistakable.
Research is growing not only on skin-conditioning and injections, but also on post-treatment recovery and use as a skincare ingredient.
While expectations for its potential continue, the emphasis on product quality, origin, manufacturing methods, and safety is growing even stronger.
The number of studies in humans has grown, and data on short-term safety has accumulated. On the other hand, “rejuvenation” and broad metabolic improvement still need to be viewed with caution.
In other words, regenerative beauty seems to be gradually shifting from “the stage of searching for a dream ingredient” to “the stage of determining how far it can practically be used.”
PDRN is short for Polydeoxyribonucleotide. It is an ingredient made up of DNA-derived fragments and was originally studied in the fields of wound healing and tissue repair.
In the beauty field today, attention is focused on its application to:
— and more.
Put simply, the idea behind PDRN is less about forcing something onto the skin and more about supporting an environment in which it can repair itself more easily.
A new systematic review published in 2026 compiled randomized controlled trials using PDRN and PN.
The studies included examined:
— and some improvement was reported.
For wound healing in particular, relatively consistent results were seen in re-epithelialization and healing time.
However, looking at the research as a whole, the number of participants is still small, and formulations, injection methods, and evaluation methods are not standardized.
In other words, PDRN is best thought of as having moved from “an ingredient that was merely hoped for in beauty” to a stage where clinical data is gradually accumulating.
In September 2026, a real-world clinical case report was also published on a serum containing plant-derived “Phyto PDRN.” This is an interesting development.
Until now, many people have associated PDRN with injectable skin-conditioning treatments, but the category itself is beginning to expand from “PDRN you receive as a treatment” to “PDRN you use every day.”
That said, a distinction needs to be made here.
Applying a cosmetic containing PDRN is not the same as having a PDRN or PN preparation injected at a medical institution.
How deep into the skin does it reach?
At what concentration?
How is the preparation itself designed?
The effect varies greatly depending on these factors.
The words “contains PDRN” alone are not enough to evaluate all products in the same way.
The two are often confused these days. PDRN and PN (polynucleotide) are talked about as closely related categories, but strictly speaking they are not the same thing.
In general, they differ in molecular size, structure, viscosity, and characteristics as a preparation. In aesthetic medicine, PN preparations are increasingly used as “skin-conditioning injections.”
For this reason,
rather than deciding based on names alone — “Is PDRN better?”
“Is PN better?”
— it’s important to look at what you want to improve and how the preparation will be used.
Exosomes are a type of extracellular vesicle. Released from cells, they carry:
— and more, playing a role in communication between cells.
You can think of them as tiny messengers that deliver information from one cell to another.
Taking advantage of this property, research is exploring applications in:
— and more.
Exosomes are a field that feels especially futuristic within regenerative beauty.
However, what has become clear as research progresses is that the name “exosome” alone tells you almost nothing.
This is because the contents differ depending on
what cells they were made from, how they were cultured, how they were isolated, how far they were purified, what they contain, and how much they contain.
More recently, it has also been discussed that even when a product is labeled “exosome,” there are cases in which it has not been sufficiently confirmed to strictly be exosomes.
In September 2026, a paper was also published on what should be explained to patients who request exosome treatment at aesthetic dermatology clinics. I think this is a development that symbolizes exosome beauty today.
The heart of the discussion is not only “does it work or not.”
— the field is moving toward the view that all of this needs to be explained.
Another review published in 2026 likewise points out that, while extracellular vesicles including exosomes show potential for skin quality and tissue repair, there is variability between studies, a lack of standardized manufacturing methods, and a lack of long-term data.
In other words, we are now in an era of looking at “what kind of exosome it is,” rather than assuming “it’s an exosome, so it’s new, so it’s good.”
It’s a little dangerous to assume that “because it’s cell-derived, it’s natural and safe.”
With exosome-related products used for cosmetic purposes, particularly in cases where they were injected,
— and other complications have been reported.
Of course, this does not mean that all exosome treatments are dangerous.
What matters more is that origin, manufacturing, quality control, and method of administration all have a major bearing on safety.
Precisely because this is regenerative beauty, you need to look at the “contents” rather than the “ingredient name.”
NMN is short for Nicotinamide Mononucleotide. It is a precursor used by the body to make NAD+.
NAD+ is involved in many aspects of life activity, including:
— and more.
Because NAD+-related metabolism changes with age, research is advancing on the idea that “maintaining NAD+ may contribute to healthy longevity and the aging process.”
For NMN, research in humans has grown considerably compared with the past.
The latest systematic review and meta-analysis, published in July 2026, examined 15 randomized controlled trials.
The key point confirmed there was that, for short-term oral NMN intake, no clear increase in serious adverse events was observed. At least regarding short-term tolerability, data is gradually accumulating.
On the other hand,
— no clear, consistent improvement was confirmed for these.
While there are some interesting signals for blood pressure and insulin sensitivity, it is too early to call them conclusions.
In other words, NMN is
neither “an ingredient with no basis whatsoever” nor “an ingredient proven to make you younger if you take it.”
With more human research, we are finally at the stage where the outline of “what it can and cannot do” is starting to come into view.
When thinking about NMN, the important thing is not to view it as a “skin treatment” in the same way as PDRN or exosomes.
NMN is not something that
“fades this spot”
“shrinks these pores”
— it’s not that kind of thing.
Rather, it is an approach that thinks about beauty from the energy metabolism and cell condition of the whole body.
Skin is part of the body, too.
When sleep deprivation continues, your complexion changes; when fatigue continues, your skin’s condition declines. So there is real meaning in thinking about skin from the perspective of energy metabolism and recovery.
At this point, however,
“NMN makes the skin look younger”
“improves wrinkles and spots”
— there isn’t yet enough clinical data to go so far as to state either of these.
It’s best to think of “the beauty effect itself” and “the body condition that forms the foundation of beauty” separately. How do PDRN, exosomes, and NMN compare?
| Comparison | PDRN / PN | Exosomes | NMN |
|---|---|---|---|
| Focus | Skin and tissue repair environment | Cell-to-cell communication | NAD+ and energy metabolism |
| Closeness to beauty | Relatively close | Relatively close | Indirect, via the whole body |
| Main areas of focus | Skin-conditioning, firmness, recovery | Repair, inflammation, skin quality | Vitality, metabolism, recovery |
| 2026 developments | A systematic review of RCTs has appeared | Discussion of quality, regulation, and safety is intensifying | Meta-analyses compiling RCTs are increasing |
| Current challenges | Small case numbers and variability in preparations and methods | Standardization, quality, long-term safety | Long-term data and clear clinical effect |
| Role in beauty | Relatively easy to incorporate into skin-conditioning | High future potential, but a careful choice is needed | Leans toward inner beauty and wellness |
Comparing them this way, you can see this is not a comparison meant to decide which one is best. The places each one looks at are simply different.
Not necessarily.
For example, if you have a distinct spot, first consider a treatment suited to that pigment.
If pores are clogged with plugs, balance the keratin and sebum.
If sagging is the cause, consider RF, HIFU, and the like.
If acne is inflamed, first treat the acne itself.
Regenerative beauty is not a substitute for these.
Rather, it is an approach that shows its strength in situations where, after receiving the necessary treatment, you want to improve skin quality and recovery.
Looking at the 2026 research, one trend becomes visible: rather than treating something with regenerative ingredients alone, the idea is to combine them with conventional aesthetic medicine.
For example:
→ Laser + care that supports skin recovery
→ Peeling + barrier and repair care
→ RF / microneedling + an approach that improves skin quality
It’s the idea of combining “treatments that create change” with “treatments that support the skin’s ability to bounce back.” This is close to the “skin-conditioning” approach that has become so common lately.
Rather than simply making the skin clear once, it’s about nurturing skin that returns easily to a good state.
Aesthetic medicine seems to be gradually expanding in that direction.
PDRN, exosomes, NMN.
A few years ago, each of these was an ingredient strongly associated with “the beauty of the future.” As of 2026, that future is gradually getting closer to reality.
For PDRN and PN, research in humans has begun to come together little by little, and the potential for skin-conditioning and post-treatment care has come into view.
For exosomes, their potential for beauty continues to draw attention, but even more clear is the importance of verifying quality control, safety, and manufacturing methods.
For NMN, the number of human studies has grown, and information on short-term safety has accumulated. The so-called “rejuvenation effect,” on the other hand, is still at the stage of being confirmed.
In other words, regenerative beauty has entered the stage of moving
from “beauty you try because it seems impressive” to “beauty you choose after identifying what you need.” There’s no need to jump at something just because it’s new. There’s no need to dismiss everything just because research is still ongoing.
How much is actually known right now?
What do I want to improve?
Is there a more established treatment available?
Sort out those three things before adopting it.
At our clinic, we believe that this kind of slightly calm, measured distance is exactly what matters for living with new beauty approaches over the long term.
Aesthetic medicine is moving from something that merely searches for “ways to look younger” to something that considers how to support the skin’s and body’s own ability to rebalance. Regenerative beauty is not yet a finished field.
But the way of thinking itself looks set to become one of the currents that will change aesthetic medicine going forward.